1. Home
  2. MOS vs BIO Comparison

MOS vs BIO Comparison

Compare MOS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mosaic Company (The)

MOS

Mosaic Company (The)

HOLD

Current Price

$21.13

Market Cap

7.3B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$296.86

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOS
BIO
Founded
1987
1952
Country
United States
United States
Employees
N/A
7450
Industry
Agricultural Chemicals
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
8.0B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
MOS
BIO
Price
$21.13
$296.86
Analyst Decision
Hold
Buy
Analyst Count
16
4
Target Price
$31.94
$339.75
AVG Volume (30 Days)
9.6M
313.5K
Earning Date
05-11-2026
04-30-2026
Dividend Yield
3.82%
N/A
EPS Growth
209.09
N/A
EPS
N/A
N/A
Revenue
$12,052,400,000.00
N/A
Revenue This Year
$9.01
$2.74
Revenue Next Year
N/A
$3.20
P/E Ratio
N/A
$9.72
Revenue Growth
8.36
N/A
52 Week Low
$19.80
$236.73
52 Week High
$38.23
$343.12

Technical Indicators

Market Signals
Indicator
MOS
BIO
Relative Strength Index (RSI) 43.79 55.17
Support Level $20.89 $293.88
Resistance Level $24.59 $314.39
Average True Range (ATR) 0.95 9.65
MACD -0.02 0.59
Stochastic Oscillator 8.67 76.74

Price Performance

Historical Comparison
MOS
BIO

About MOS Mosaic Company (The)

Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in the US and potash mines in Canada. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: